Last week NCITA held its 3rd live webinar on Friday 31st July 2020 on ‘Optimizing Application of Imaging in Trials’. This was the final session of a series of three live webinars which replaced the NCITA Annual National Conference, cancelled due to the COVID19 pandemic.
The Webinar recording is now available here to watch again or to listen to if you missed the live session.
In the Webinar we hosted three live talks. Professor Sue Mallett from the Centre for Medical Imaging at UCL discussed the importance of getting the biostatistics right when designing imaging biomarker studies, identifying and assessing risk of bias and plans for collaboration with the NCITA statistical collaborative team.
Professor Hashim Ahmed from Imperial College London discussed ‘Clinical Trials and the Impact of Clinical Advances in Prostate Cancer’, in particular his experience with the large pivotal PROMIS study in determining the validity of prostate multiparametric MRI (mpMRI) in the diagnostic pathway for prostate cancer.
Finally Professor Shonit Punwani Centre for Medical Imaging UCL focused on the challenges of imaging techniques such as mpMRI and the importance of early development work in the translational pipeline, in particular experiences from the VERDICT MRI study (Vascular Extracellular and Restricted Diffusion for Cytometry in Tumors). Professor Punwani also discussed the successes and opportunities of novel imaging techniques such as 13C Hyperpolarised MRI.
If you would like to learn more about our NCITA infrastructure support, please contact us at email@example.com